Yan-Wu Xu
Overview
Explore the profile of Yan-Wu Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li H, Luo Z, Huang M, Cai H, Lu P, Xu Y, et al.
Curr Pharm Des
. 2025 Jan;
PMID: 39781735
Introduction: Taohong Siwu decoction (THSWD), a traditional prescription for enhancing blood circulation and eliminating blood stasis, primarily comprises peach kernel, safflower, angelica, chuanxiong, and rehmannia. Modified Taohong Siwu decoction (MTHSWD),...
2.
Gong D, Li W, Li X, Wan C, Zhou Y, Wang S, et al.
Int J Ophthalmol
. 2024 Dec;
17(12):2308-2315.
PMID: 39697896
This paper analyzes the current status, technological developments, academic exchange platforms, and future challenges and solutions in the field of intelligent ophthalmology (IO) in China. In terms of technology, significant...
3.
Wu X, Fang H, Xu Y, Zhang Y, Zhang S, Yang W
Int J Ophthalmol
. 2024 May;
17(5):940-950.
PMID: 38766336
Aim: To gain insights into the global research hotspots and trends of myopia. Methods: Articles were downloaded from January 1, 2013 to December 31, 2022 from the Science Core Database...
4.
Wang L, Yang Y, Chen L, He Z, Bi D, Zhang L, et al.
Front Pharmacol
. 2024 Jan;
14:1320322.
PMID: 38186655
[This corrects the article DOI: 10.3389/fphar.2021.621359.].
5.
Yang W, Shao Y, Xu Y
Int J Ophthalmol
. 2023 Sep;
16(9):1361-1372.
PMID: 37724285
With the upsurge of artificial intelligence (AI) technology in the medical field, its application in ophthalmology has become a cutting-edge research field. Notably, machine learning techniques have shown remarkable achievements...
6.
Li H, Zhu J, Xu Y, Mou F, Shan X, Wang Q, et al.
Redox Biol
. 2022 Jul;
54:102384.
PMID: 35777198
Notoginsenoside R1 (NGR1) is the main monomeric component extracted from the dried roots and rhizomes of Panax notoginseng, and exerts pharmacological action against myocardial infarction (MI). Owing to the differences...
7.
Wang L, Yang Y, Chen L, He Z, Bi D, Zhang L, et al.
Front Pharmacol
. 2021 Apr;
12:621359.
PMID: 33897417
Compound Dihuang Granule (CDG) is widely used in traditional Chinese medicine (TCM) for the treatment of Parkinson's disease (PD). It has been shown to alleviate PD symptoms. However, the molecular...
8.
Wang X, Xia H, Qin H, Kang X, Hu H, Zheng J, et al.
J Cell Biochem
. 2018 Sep;
120(4):5085-5096.
PMID: 30259568
20(S)-protopanaxadiol (PPD)-type ginsenosides are generally believed to be the most pharmacologically active components of Panax ginseng. These compounds induce apoptotic cell death in various cancer cells, which suggests that they...
9.
Cui G, Wu J, Mou F, Xie W, Wang F, Wang Q, et al.
FASEB J
. 2017 Oct;
32(2):654-668.
PMID: 28970251
Administration of exosomes derived from mesenchymal stromal cells (MSCs) could improve some neurologic conditions by transferring functional biomolecules to recipient cells. Furthermore, exosomes from hypoxic progenitor cells exerted better therapeutic...
10.
Cao T, Chen H, Dong Z, Xu Y, Zhao P, Guo W, et al.
Cell Physiol Biochem
. 2017 May;
42(1):103-114.
PMID: 28494450
Background: Autophagy is required for the maintenance of cardiomyocyte homeostasis. However, excessive autophagy plays a maladaptive role in pressure overload-induced heart failure. To identify mechanisms by which Stachydrine inhibits pressure...